Depleted HDAC3 attenuates hyperuricemia-induced renal interstitial fibrosis via miR-19b-3p/SF3B3 axis

Cell Cycle. 2022 Mar;21(5):450-461. doi: 10.1080/15384101.2021.1989899. Epub 2022 Jan 13.

Abstract

Dysfunctional histone deacetylases (HDACs) elicit unrestrained fibrosis and damage to organs. With regard to the link between HDACs and fibrosis, this research is practiced to decipher the concrete mechanism of HDAC3 in hyperuricemia (HN)-induced renal interstitial fibrosis (RIF) from microRNA-19b-3p/splicing factor 3b subunit 3 (miR-19b-3p/SF3B3) axis.The HN model was established on rats to induce RIF by oral administration of adenine and potassium oxalate. HN rats were injected with miR-19b-3p- or HDAC3-related vectors to figure out their effects on RIF through detecting 24-h urine protein, uric acid (UA), blood urea nitrogen (BUN) and serum creatinine (Scr) contents and α-smooth muscle actin (α-SMA), transforming growth factor β1 (TGF-β1) and fibronectin (FN) contents in renal tissues and observing pathological damages and RIF index of renal tissues. HDAC3, miR-19b-3p and SF3B3 expression in renal tissues were tested, along with their interactions.Elevated HDAC3 and SF3B3 and reduced miR-19b-3p were displayed in renal tissues of HN rats. Suppressed HDAC3 or promoted miR-19b-3p relieved HN-induced RIF, as reflected by their inhibitory effects on 24 h urine protein, UA, BUN, Scr, α-SMA, TGF-β1, and FN contents and RIF index and their ameliorated effects on pathological damages of renal tissues. HDAC3 bound to the promoter of miR-19b-3p to regulate SF3B3. MiR-19b-3p depletion abrogated down-regulated HDAC3-induced effects on HN-induced RIF.It is delineated that depressed HDAC3 relives HN-induced RIF through restoring miR-19b-3p and knocking down SF3B3, replenishing the references for RIF curing.

Keywords: Renal interstitial fibrosis; histone deacetylase 3; hyperuricemia; microRNA-19b-3p; splicing factor 3b subunit 3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Fibrosis
  • Histone Deacetylases / metabolism*
  • Humans
  • Hyperuricemia* / complications
  • Hyperuricemia* / drug therapy
  • Kidney Diseases* / drug therapy
  • Kidney Diseases* / etiology
  • Kidney Diseases* / metabolism
  • Male
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • RNA Splicing Factors
  • Rats
  • Transforming Growth Factor beta1 / metabolism

Substances

  • MicroRNAs
  • RNA Splicing Factors
  • SF3B3 protein, human
  • Transforming Growth Factor beta1
  • Histone Deacetylases
  • histone deacetylase 3

Grants and funding

This work is supported by Hainan key research and development projects (ZDYF2019126), Development Fund Project of Hainan medical college (HYPY201926), National Natural Science Foundation of China (82160135), Hainan Province Clinical Medical Center and Projects of Hainan General Hospital (2021MSXM17,2021QNXM03,06,12,13).